Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Pathology and Clinical Laboratory Medicine, |
RCV000853233 | SCV000996296 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 | criteria provided, single submitter | clinical testing | ||
Centre for Mendelian Genomics, |
RCV000853233 | SCV001369949 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 | 2020-01-27 | criteria provided, single submitter | clinical testing | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PP3. |
Baylor Genetics | RCV000853233 | SCV001521029 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 | 2024-02-28 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV001683668 | SCV001905652 | pathogenic | not provided | 2021-09-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001869305 | SCV002136342 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2K; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1; Walker-Warburg congenital muscular dystrophy | 2024-01-09 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 4 of the POMT1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. This variant is present in population databases (rs746823238, gnomAD 0.0009%). Disruption of this splice site has been observed in individual(s) with Walker-Warburg syndrome (PMID: 18752264, 20065251). This variant is also known as p.del77-93. ClinVar contains an entry for this variant (Variation ID: 691982). Studies have shown that disruption of this splice site results in skipping of exon 4, but is expected to preserve the integrity of the reading-frame (PMID: 20065251). For these reasons, this variant has been classified as Pathogenic. |
Center for Genomic Medicine, |
RCV000853233 | SCV004806002 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 | 2024-03-25 | criteria provided, single submitter | clinical testing | |
Equipe Genetique des Anomalies du Developpement, |
RCV000853233 | SCV004847199 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 | 2023-08-28 | criteria provided, single submitter | clinical testing |